Blue Diesel

Share this article:
Company Profile
With extensive expertise in the pharmaceutical and healthcare arena, Blue Diesel understands the demands and challenges that drive the industries and the many audiences they serve—from healthcare professionals and payors, to caregivers and patients. Blue Diesel provides the necessary solutions to connect with each audience, and does so with a powerful blend of strategic innovation and proven experience.

In order to service clients more effectively, Blue Diesel has two office locations. The Midwest headquarters is based just outside of Columbus, Ohio, while the East Coast office is situated near Philadelphia, in Newtown, Pennsylvania. Segmented into domains of strategy, creative, technology, client services, and operations, the agency leverages talent from these disciplines to surround clients with a core group of smart, savvy, hard-working professionals who excel at turning client challenges into opportunity. These teams, called “studios,” are intentionally structured to deepen relationships, strengthen knowledge, and maximize efficiency.

Blue Diesel is part of inVentiv Health (NASDAQ: VTIV), a leading provider of commercialization and complementary services to the global pharmaceutical, life sciences, and biotechnology industries.

Services and Offerings
Founded in 1995, Blue Diesel has a strong foundation in interactive marketing supported by a deep understanding of traditional channels. This blend of experience, along with focused attention on the pharmaceutical and healthcare industries, positions the agency as a strong, capable partner with a diverse range of category experience.

Creative, compelling and award-winning services include:
  • Interactive and Brand Strategy
  • Website Design & Development
  • Closed-loop Marketing & Tablet PC Solutions
  • Mobile Marketing
  • Online Marketing & Advertising
  • Video & 3-D Animation

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.